Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Performer
3595.5000 34.50 (0.97%)
NSE Sep 29, 2025 09:52 AM
Volume: 24,240
 

3595.50
0.97%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 16% YoY to | 1429 crore (I-direct estimate: | 1583 crore) mainly due to 55% YoY de-growth in the US to | 322 crore (I-direct estimate: | 443 crore). The decline in US sales was due to the high base of gAbilify exclusivity in Q2FY16. Domestic revenue grew 13% YoY at | 496 crore (I-direct estimate: | 479 crore) EBITDA margins declined to 23.1% (I-direct estimate: 30.0%) vs....
Torrent Pharmaceuticals Ltd. is trading below its 30 day SMA of 3603.8
More from Torrent Pharmaceuticals Ltd.
Recommended